LVW Advisors LLC Sells 901 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

LVW Advisors LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 30.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,059 shares of the healthcare conglomerate's stock after selling 901 shares during the quarter. LVW Advisors LLC's holdings in UnitedHealth Group were worth $1,041,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. State Street Corp boosted its holdings in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock worth $11,440,133,000 after purchasing an additional 318,039 shares during the last quarter. Franklin Resources Inc. lifted its position in UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock worth $4,884,019,000 after buying an additional 193,800 shares in the last quarter. International Assets Investment Management LLC increased its position in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its stake in shares of UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock valued at $1,920,039,000 after purchasing an additional 21,149 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of brokerages have commented on UNH. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. UBS Group lowered their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a report on Wednesday, October 16th. Finally, TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH traded down $0.56 during midday trading on Monday, hitting $510.03. The stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a 50 day simple moving average of $549.37 and a two-hundred day simple moving average of $563.70. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business's revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.83 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.